is glp-1 a scam New Study Finds Online Advertising for Compounded Diabetes and Weight-Loss Drugs May Mislead Consumers New weight-loss scams fueled by

While vigorous activity and exercise must wait 57 weeks, most patients can resume desk work after two weeks

American College of Rheumatology: Tirzepatide and Joint Pain Risk - Study showing reduced joint pain risk with tirzepatide compared to other weight loss medications

Lancet 381 , 117124 (2013)

despite being taken as a daily pill rather than injection, it contains the same active ingredient and allegedly carries similar risks Mounjaro (tirzepatide): Manufactured by Eli Lilly and approved in May 2022, this medication works as a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, offering enhanced blood sugar control and weight loss effects but also allegedly causing severe gastrointestinal injuries similar to semaglutide products Trulicity (dulaglutide): Eli Lillys once-weekly GLP-1 injection approved in 2014 for type 2 diabetes

Pharmacies that conduct their own stability studies can typically assign longer BUDs (60-120 days)